Minireview: Cyclin D1: normal and abnormal functions.

Cyclin D1 encodes the regulatory subunit of a holoenzyme that phosphorylates and inactivates the retinoblastoma protein and promotes progression through the G1-S phase of the cell cycle. Amplification or overexpression of cyclin D1 plays pivotal roles in the development of a subset of human cancers including parathyroid adenoma, breast cancer, colon cancer, lymphoma, melanoma, and prostate cancer. Of the three D-type cyclins, each of which binds cyclin-dependent kinase (CDK), it is cyclin D1 overexpression that is predominantly associated with human tumorigenesis and cellular metastases. In recent years accumulating evidence suggests that in addition to its original description as a CDK-dependent regulator of the cell cycle, cyclin D1 also conveys cell cycle or CDK-independent functions. Cyclin D1 associates with, and regulates activity of, transcription factors, coactivators and corepressors that govern histone acetylation and chromatin remodeling proteins. The recent findings that cyclin D1 regulates cellular metabolism, fat cell differentiation and cellular migration have refocused attention on novel functions of cyclin D1 and their possible role in tumorigenesis. In this review, both the classic and novel functions of cyclin D1 are discussed with emphasis on the CDK-independent functions of cyclin D1.

[1]  J. Magaud,et al.  Implication of cyclin D1 in malignant lymphoma. , 1996, Critical reviews in oncogenesis.

[2]  C. Sherr,et al.  Gene Expression and Cell Cycle Arrest Mediated by Transcription Factor DMP1 Is Antagonized by D-Type Cyclins through a Cyclin-Dependent-Kinase-Independent Mechanism , 1998, Molecular and Cellular Biology.

[3]  Sehwan Han,et al.  Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer. , 2003, Oncology reports.

[4]  C. Albanese,et al.  Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. , 2003, Journal of the National Cancer Institute.

[5]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[6]  Amanda Y. Chan,et al.  Cyclin D1 governs adhesion and motility of macrophages. , 2003, Molecular biology of the cell.

[7]  C. Albanese,et al.  Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.

[8]  M. Ewen,et al.  Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 , 1997, Molecular and cellular biology.

[9]  W. Cavenee,et al.  D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. , 1999, Cancer research.

[10]  J. Lamb,et al.  Regulation of the Functional Interaction between Cyclin D1 and the Estrogen Receptor , 2000, Molecular and Cellular Biology.

[11]  S. Elledge,et al.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast , 1995, Cell.

[12]  Y. Hosokawa,et al.  Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: Analysis of allele‐specific expression , 1998, Genes, chromosomes & cancer.

[13]  P. Robbins,et al.  Cyclin D1 Associates with the TBP-associated factor TAFII250 to regulate Sp1-mediated transcription , 1999, Oncogene.

[14]  J. Pollard,et al.  Genetic Evidence for the Interactions of Cyclin D1 and p27Kip1 in Mice , 2001, Molecular and Cellular Biology.

[15]  M. Groudine,et al.  Controlling the double helix , 2003, Nature.

[16]  J. Segall,et al.  The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. , 1999, Endocrine reviews.

[17]  T. Oyama,et al.  Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. , 1998, Cancer research.

[18]  A. Arnold,et al.  The putative oncogene PRAD1 encodes a novel cyclin. , 1991, Cold Spring Harbor symposia on quantitative biology.

[19]  K. Knudsen,et al.  Specificity of cyclin D1 for androgen receptor regulation. , 2003, Cancer research.

[20]  Puneeth Iyengar,et al.  Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization , 2003, Oncogene.

[21]  C. Albanese,et al.  TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. , 2001, Molecular biology of the cell.

[22]  T. Tsuzuki,et al.  Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. , 1999, Kidney international.

[23]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[24]  Richard J. Lee,et al.  pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. , 1999, The Journal of biological chemistry.

[25]  K. Knudsen,et al.  Cyclin D1: Mechanism and Consequence of Androgen Receptor Co-repressor Activity* , 2002, The Journal of Biological Chemistry.

[26]  M. Ewen,et al.  P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Richard J. Lee,et al.  Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis* , 1999, The Journal of Biological Chemistry.

[28]  C. Amos,et al.  Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. , 2000, Cancer research.

[29]  M. Pagano,et al.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.

[30]  Barbara Wold,et al.  HLH forced dimers: Tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id , 1993, Cell.

[31]  Tony Kouzarides,et al.  Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.

[32]  M. Vasef,et al.  Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[33]  Chenguang Wang,et al.  Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential. , 2004, Cancer treatment and research.

[34]  Y. Yarden,et al.  Cyclin D1 Is Required for Transformation by Activated Neu and Is Induced through an E2F-Dependent Signaling Pathway , 2000, Molecular and Cellular Biology.

[35]  T. Braun,et al.  Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5. , 1992, Genes & development.

[36]  R. Buckle,et al.  Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. , 1998, Genes & development.

[37]  L. Donehower,et al.  The Integrin-linked Kinase Regulates the Cyclin D1 Gene through Glycogen Synthase Kinase 3β and cAMP-responsive Element-binding Protein-dependent Pathways* , 2000, The Journal of Biological Chemistry.

[38]  M. Rudnicki,et al.  Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development , 1992, Cell.

[39]  D. Barnes,et al.  Cyclin D1 in Breast Cancer , 2004, Breast Cancer Research and Treatment.

[40]  Q. Wei,et al.  Coupling of the cell cycle and myogenesis through the cyclin D1‐dependent interaction of MyoD with cdk4 , 1999, The EMBO journal.

[41]  M. Tsai,et al.  Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. , 1995, Genes & development.

[42]  David Baltimore,et al.  Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo , 1991, Cell.

[43]  K. Wolff,et al.  Fibroblast Growth Factor-2 Induces Lef/Tcf-dependent Transcription in Human Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[44]  J. Turkson,et al.  STAT proteins: novel molecular targets for cancer drug discovery , 2000, Oncogene.

[45]  J. Marshall,et al.  Novel strategies in cancer therapeutics: targeting enzymes involved in cell cycle regulation and cellular proliferation. , 2004, Current cancer drug targets.

[46]  L. Schuler,et al.  PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. , 2002, Molecular endocrinology.

[47]  Itaru Matsumura,et al.  Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine‐dependent growth of hematopoietic cells , 1999, The EMBO journal.

[48]  I. Weinstein.  Relevance of cyclin D1 and other molecular markers to cancer chemoprevention , 1996, Journal of cellular biochemistry. Supplement.

[49]  C. J. Chen,et al.  Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. , 1993, Biochemical and biophysical research communications.

[50]  D. Stacey.  Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. , 2003, Current opinion in cell biology.

[51]  R. Tennant,et al.  Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. , 1998, Genes & development.

[52]  T. Hwang,et al.  Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients , 2003, Pathology international.

[53]  A. Arnold,et al.  Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. , 1996, The Journal of clinical endocrinology and metabolism.

[54]  M. Roussel,et al.  Signaling by ABL oncogenes through cyclin D1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[55]  B. Spiegelman,et al.  Molecular regulation of adipogenesis. , 2000, Annual review of cell and developmental biology.

[56]  M. Masuda,et al.  Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. , 2002, Cancer research.

[57]  A. Arnold,et al.  Cyclin D1 in parathyroid disease. , 2000, Frontiers in bioscience : a journal and virtual library.

[58]  J. Diehl.  Cycling to Cancer with Cyclin D1 , 2002, Cancer biology & therapy.

[59]  V. Sukhatme,et al.  Endostatin Causes G1 Arrest of Endothelial Cells through Inhibition of Cyclin D1* , 2002, The Journal of Biological Chemistry.

[60]  A. Leiter,et al.  Cyclin D1 Represses the Basic Helix-Loop-Helix Transcription Factor, BETA2/NeuroD* , 2002, The Journal of Biological Chemistry.

[61]  A. Senderowicz,et al.  Cyclin D1 Splice Variants , 2003, Journal of Biological Chemistry.

[62]  D. Bortner,et al.  Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E , 1997, Molecular and cellular biology.

[63]  M. Hung,et al.  β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression , 2000 .

[64]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[65]  T. Habuchi,et al.  Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. , 2002, Carcinogenesis.

[66]  R. Pestell,et al.  Amino Acids Regulate Hepatocyte Proliferation through Modulation of Cyclin D1 Expression* , 2003, Journal of Biological Chemistry.

[67]  C. Amos,et al.  Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. , 2001, Journal of the National Cancer Institute.

[68]  E. Rosen,et al.  Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell Growth , 2003, Molecular and Cellular Biology.

[69]  S. Safe,et al.  Peroxisome Proliferator-activated Receptor γ Agonists Induce Proteasome-dependent Degradation of Cyclin D1 and Estrogen Receptor α in MCF-7 Breast Cancer Cells , 2003 .

[70]  T. Rowlands,et al.  β-Catenin and Tcfs in Mammary Development and Cancer , 2003, Journal of Mammary Gland Biology and Neoplasia.

[71]  H. Kamada,et al.  Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner , 1998, Oncogene.

[72]  T. Golub,et al.  A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.

[73]  F. C. Lucibello,et al.  Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. , 1994, Oncogene.

[74]  F. C. Lucibello,et al.  Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation , 1999, Oncogene.

[75]  D. Amanatullah,et al.  Ras regulation of cyclin D1 promoter. , 2001, Methods in enzymology.

[76]  H. Koeffler.  Peroxisome proliferator-activated receptor γ and cancers , 2003 .

[77]  J. Lamb,et al.  Cyclin D1 and Molecular Chaperones: Implications for Tumorigenesis , 2003, Cell cycle.

[78]  J. Diehl,et al.  Cell cycle progression without cyclin E/CDK2: breaking down the walls of dogma. , 2003, Cancer cell.

[79]  R. Bernards,et al.  CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.

[80]  D. Chung.  Cyclin D1 in Human Neuroendocrine: Tumorigenesis , 2004, Annals of the New York Academy of Sciences.

[81]  R. Bronson,et al.  Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Yan Geng,et al.  Cyclin E Ablation in the Mouse , 2003, Cell.

[83]  A. Dey,et al.  Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages. , 2000, Biochimica et biophysica acta.

[84]  Chris Albanese,et al.  Gastrin-mediated activation of cyclin D1 transcription involves β-catenin and CREB pathways in gastric cancer cells , 2004, Oncogene.

[85]  T. Habuchi,et al.  Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism , 2003, International journal of cancer.

[86]  J.M. Adams,et al.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.

[87]  J. Sloane,et al.  Immunodetectable cyclin D 1 is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions , 2001, British Journal of Cancer.

[88]  M. Krstic-Demonacos,et al.  Acetylation control of the retinoblastoma tumour-suppressor protein , 2001, Nature Cell Biology.

[89]  J. Guan,et al.  Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. , 2001, Molecular biology of the cell.

[90]  K. Klempnauer,et al.  Regulation of B-Myb activity by cyclin D1 , 2000, Oncogene.

[91]  B. Calabretta,et al.  Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[92]  L. Zon,et al.  Induction of cyclin D1 by simian virus 40 small tumor antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[93]  Jiri Bartek,et al.  Cyclin D1 protein expression and function in human breast cancer , 1994, International journal of cancer.

[94]  R. Weinberg,et al.  Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[95]  A. Lassar,et al.  Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation , 1996, Molecular and cellular biology.

[96]  A. Arnold,et al.  PRAD1/lCyclin D1 proto‐oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor‐specific rearrangement breakpoint , 1993 .

[97]  O. Jänne,et al.  Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. , 2001, Molecular endocrinology.

[98]  S. Gansauge,et al.  Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. , 1997, Cancer research.

[99]  S. Akira,et al.  Signal transducer and activator of transcription protein (STAT): its relation to Th1/Th2-mediated diseases. , 1997, Nutrition.

[100]  G. Stamp,et al.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.

[101]  L. Marchand,et al.  Association of the Cyclin D 1 A 870 G Polymorphism With Advanced Colorectal Cancer , 2003 .

[102]  D. Dean,et al.  Rb Interacts with Histone Deacetylase to Repress Transcription , 1998, Cell.

[103]  W. Sellers,et al.  Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity , 2000, Oncogene.

[104]  Lawrence A. Donehower,et al.  Cyclin D1 Repression of Peroxisome Proliferator-Activated Receptor γ Expression and Transactivation , 2003, Molecular and Cellular Biology.

[105]  C. Brosnan,et al.  Interferon‐β activates multiple signaling cascades in primary human microglia , 2002 .

[106]  J. Harbour,et al.  Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.

[107]  Charles J. Sherr,et al.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1 , 1985, Cell.

[108]  Pierre Dubus,et al.  Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice , 2003, Nature Genetics.

[109]  Emma Lees,et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.

[110]  Charles B. Hall,et al.  Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. , 2001, The Journal of clinical investigation.

[111]  Chris Albanese,et al.  Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[112]  Duanduan Ma,et al.  Exit from G1 and S Phase of the Cell Cycle Is Regulated by Repressor Complexes Containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF , 2000, Cell.

[113]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[114]  L. Augenlicht,et al.  Cyclin D1 Genetic Heterozygosity Regulates Colonic Epithelial Cell Differentiation and Tumor Number in ApcMin Mice , 2004, Molecular and Cellular Biology.

[115]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[116]  R. M. Böhmer,et al.  Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. , 1996, Molecular biology of the cell.

[117]  K. Franssila,et al.  Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. , 2001, American Journal of Pathology.

[118]  C. Sherr,et al.  Principles of Tumor Suppression , 2004, Cell.

[119]  B. Cochran,et al.  Role of the JAK-STAT pathway in PDGF-stimulated proliferation of human airway smooth muscle cells. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[120]  P. Peltomäki,et al.  CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. , 2001, Cancer research.

[121]  C. Sherr.  The Pezcoller lecture: cancer cell cycles revisited. , 2000, Cancer research.

[122]  H. Gascan,et al.  Cyclin D1 Represses STAT3 Activation through a Cdk4-independent Mechanism* , 2001, The Journal of Biological Chemistry.

[123]  Li Zhao,et al.  Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors* , 2002, The Journal of Biological Chemistry.

[124]  H. Höfler,et al.  Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events. , 2003, The American journal of pathology.